Primary Liver Cancer: Chemical Carcinogenesis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/978-1-60327-376-3_3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene

  2009cited by this paper
• Nonalcoholic fatty liver disease The author's work is supported by a Merit Award from the Department of Veterans Affairs and by DK-072187 from the National Institutes of Health. Published, JLR Papers in Press, December 12, 2008.

  2009cited by this paper
• Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron.

  2009cited by this paper
• Promotion of hepatocarcinogenesis in humans and animal models

  2008cited by this paper
• Natural history of hepatitis-related hepatocellular carcinoma.

  2008cited by this paper
• Alcohol, cofactors and the genetics of hepatocellular carcinoma

  2008cited by this paper
• Liver Disease in Alpha 1-Antitrypsin Deficiency: A Review

  2008cited by this paper
• Mouse models in liver cancer research: a review of current literature.

  2008cited by this paper
• Evolving trends in nonalcoholic fatty liver disease.

  2008cited by this paper
• Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus

  2008cited by this paper
• Experimental models of hepatocellular carcinoma.

  2008cited by this paper
• Risk of hepatocellular carcinoma in alcoholic cirrhosis.

  2008cited by this paper
• Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.

  2008cited by this paper
• Mechanisms of hepatic fibrogenesis.

  2008cited by this paper
• Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1

  2008cited by this paper
• Persistent and remodeling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl‐2 and NF‐κB pathways

  2008cited by this paper
• Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism

  2008cited by this paper
• Liver cancer stem cells.

  2008cited by this paper
• PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.

  2008cited by this paper
• Hepatic steatosis: a benign disease or a silent killer.

  2008cited by this paper
• Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature.

  2008cited by this paper
• Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

  2008cited by this paper
• Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.

  2008cited by this paper
• Hepatocellular carcinoma in long-term oral contraceptive use.

  2008cited by this paper
• Viral hepatocarcinogenesis: from infection to cancer

  2008cited by this paper
• Animal models of NASH: Getting both pathology and metabolic context right

  2008cited by this paper
• Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study

  2008cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.

  2007cited by this paper
• Hepatocellular carcinoma associated with recreational anabolic steroid use

  2007cited by this paper
• Correlation analysis of liver tumor-associated genes with liver regeneration.

  2007cited by this paper
• Downregulation of citrin, a mitochondrial AGC, is associated with apoptosis of hepatocytes.

  2007cited by this paper
• Citrin/Mitochondrial Glycerol-3-phosphate Dehydrogenase Double Knock-out Mice Recapitulate Features of Human Citrin Deficiency*

  2007cited by this paper
• Evidence for the Hormone Dependency of Hepatic Hyperplastic Nodules: Inhibition of Malignant Transformation After Exogenous 17β‐Estradiol and Tamoxifen

  2007cited by this paper
• Aryl‐hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver

  2007cited by this paper
• Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis.

  2007cited by this paper
• Nutrients intake and the risk of hepatocellular carcinoma in Italy.

  2007cited by this paper
• Animal models of tyrosinemia.

  2007cited by this paper
• Adventures in hepatocarcinogenesis.

  2007cited by this paper
• Diabetes and liver disease: an ominous association.

  2007cited by this paper
• Phenobarbital Confers its Diverse Effects by Activating the Orphan Nuclear Receptor Car

  2006cited by this paper
• Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

  2006cited by this paper
• Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.

  2006cited by this paper
• Detection and identification of microcystins in the drinking water of Haimen City, China.

  2006cited by this paper
• Human Response to Dioxin: Aryl Hydrocarbon Receptor (AhR) Molecular Structure, Function, and Dose-Response Data for Enzyme Induction Indicate an Impaired Human AhR

  2006cited by this paper
• Genetics of hepatocellular tumors

  2006cited by this paper
• Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy

  2006cited by this paper
• Hepatocellular Carcinoma Associated with Hereditary Hemochromatosis Occurring in Non-Cirrhotic Liver

  2006cited by this paper
• Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.

  2006cited by this paper
• Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair

  2006cited by this paper
• Gene expression profile by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the liver of wild-type (AhR+/+) and aryl hydrocarbon receptor-deficient (AhR-/-) mice.

  2006cited by this paper
• Molecular pathogenesis of hepatocellular carcinoma.

  2006cited by this paper
• Update: cohort mortality study of workers highly exposed to polychlorinated biphenyls (PCBs) during the manufacture of electrical capacitors, 1940-1998

  2006cited by this paper
• Mode of action in relevance of rodent liver tumors to human cancer risk.

  2006cited by this paper
• Food groups and risk of hepatocellular carcinoma: A multicenter case‐control study in Italy

  2006cited by this paper
• Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.

  2006cited by this paper
• Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis.

  2005cited by this paper
• Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

  2005cited by this paper
• Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions

  2005cited by this paper
• Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Genotype–phenotype relationships in hepatocellular tumors from mice and man

  2005cited by this paper
• Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?

  2005cited by this paper
• Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver

  2005cited by this paper
• Epidemiology and natural history of hepatocellular carcinoma.

  2005cited by this paper
• Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

  2005cited by this paper
• Aflatoxin and hepatitis B virus biomarkers: A paradigm for complex environmental exposures and cancer risk

  2005cited by this paper
• Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

  2004cited by this paper
• Multiple targeting by the antitumor drug tamoxifen: a structure-activity study.

  2004cited by this paper
• Aryl hydrocarbon receptor‐mediated suppression of GH receptor and Janus kinase 2 expression in mice

  2004cited by this paper
• Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions

  2004cited by this paper
• Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma.

  2004cited by this paper
• Environmental factors and risk for hepatocellular carcinoma.

  2004cited by this paper
• Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

  2004cited by this paper
• The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice

  2004cited by this paper
• Iron, hemochromatosis, and hepatocellular carcinoma.

  2004cited by this paper
• The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment.

  2004cited by this paper
• A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.

  2004cited by this paper
• A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice

  2004cited by this paper
• Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.

  2004cited by this paper
• Contributions of β2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1 −/− and β2mRag1 −/− double knock-out mice

  2004cited by this paper
• Be fit or be sick: peroxisome proliferator-activated receptors are down the road.

  2004cited by this paper
• Hepatocellular carcinoma associated with Wilson's disease.

  2004cited by this paper
• Slc25a13-Knockout Mice Harbor Metabolic Deficits but Fail To Display Hallmarks of Adult-Onset Type II Citrullinemia

  2004cited by this paper
• Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism.

  2004cited by this paper
• Differentially expressed transcripts in neoplastic hepatic nodules and neonatal rat liver studied by cDNA microarray analysis

  2003cited by this paper
• Rating fibrosis progression in chronic liver diseases.

  2003cited by this paper
• Cirrhosis: new research provides a basis for rational and targeted treatments

  2003cited by this paper
• Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation.

  2003cited by this paper
• The Epidemiology of Hepatitis C Virus Infection

  2003cited by this paper
• Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan

  2003cited by this paper
• HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.

  2003cited by this paper
• Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.

  2003cited by this paper
• Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis

  2003cited by this paper
• PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance

  2003cited by this paper
• Polymorphisms in the human AH receptor.

  2002cited by this paper
• Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.

  2002cited by this paper
• Pathology and Pathogenesis of Hepatocellular Carcinoma

  2002cited by this paper
• Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

  2002cited by this paper

• Revealing curcumin therapeutic targets on SRC, PPARG, MAPK8 and HSP90 as liver cirrhosis therapy based on comprehensive bioinformatic study

  2024cites this paper
• RNA adduction derived from electrophilic species in vitro and in vivo.

  2021cites this paper
• Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.

  2018cites this paper
• Oleanolic acid but not ursolic acid induces cell death in HepG2 cells under starvation-induced autophagy

  2012cites this paper